Pay in 4 interest-free payments of $6.54 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
GLP-1 Therapies: Balancing Clinical Benefits with Environmental Impact There is an irony: by tackling obesity and diabetes, GLP-1s could reduce the incidence of cardiovascular disease, kidney failure, and other conditions each of which carries a heavy environmental cost through surgeries, hospitalizations, and long-term drug use
Inflammatory diseases are responsible for 50% of annual deaths, highlighting the importance of maintaining low inflammation levels
More news resources FDA Medwatch Drug Alerts Daily MedNews News for Health Professionals New Drug Approvals New Drug Applications Drug Shortages Clinical Trial Results Generic Drug Approvals Drugs.com Podcast Subscribe to our newsletter Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.
Become a member today to get access
This shift is reshaping market dynamics, with evolving regulatory oversight on Ozempic alternatives, emerging price competition across brands, and expanding investment opportunities in Indias pharmaceutical and biopharma manufacturing ecosystem
US$ 27.09
US$ 29.36
US$ 28.28
US$ 21.45
US$ 24.40
US$ 21.76
US$ 25.45
US$ 21.83
US$ 25.93
US$ 23.24
